Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- LY3884963Phase 21 trial
Prevail Therapeutics · Frontotemporal Dementia
- LY3938577Phase 21 trial
Eli Lilly · Diabetes Mellitus, Type 2
- LY3972406Phase 21 trial
Eli Lilly · Plaque Psoriasis
- LY4086940Phase 21 trial
Eli Lilly · Obesity, Overweight
- LY4100511Phase 21 trial
DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company · Plaque Psoriasis
- LY4515100Phase 21 trial
Eli Lilly · Acute Pain, Molar, Molar, Third
- LYL273Phase 21 trial
Lyell Immunopharma, Inc. · Colorectal Cancer
- LYS006Phase 21 trial
Novartis · Hidradenitis Suppurativa
- LYT-200Phase 21 trial
PureTech · Metastatic Cancer, Solid Tumor, Head and Neck Cancer
- M5717Phase 21 trial
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany · Malaria Infection
- M6223Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- MAR002Phase 21 trial
Marea Therapeutics · Acromegaly
- MAX-001Phase 21 trial
Maxona Pharmaceuticals, Inc. · Impacted Third Molar Tooth, Tooth Extraction Status Nos
- MAX-40279Phase 21 trial
Maxinovel Pty., Ltd. · Acute Myeloid Leukemia
- MB-001Phase 21 trial
Mage Biologics · Ulcerative Colitis (UC)
- MBF-015Phase 21 trial
Medibiofarma S.L. · Huntington Disease
- MBK-01Fecal Microbiota Transplantation, Intestinal Microbiota TransplantationPhase 21 trial
Mikrobiomik Healthcare Company S.L. · Diverticulitis, Diverticulitis of Sigmoid
- MBS303Phase 21 trial
Beijing Mabworks Biotech Co., Ltd. · Non-Hodgkin's Lymphoma
- MDSY-1240Phase 21 trial
Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic
- MDX2001Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer
- MDX2003Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Lymphoma, Waldenström Macroglobulinemia (WM), DLBCL - Diffuse Large B Cell Lymphoma
- MDX2004Phase 21 trial
ModeX Therapeutics, An OPKO Health Company · Advanced Tumors
- ME-401Phase 21 trial
Kyowa Kirin Co., Ltd. · Indolent B-cell Non-Hodgkin's Lymphoma
- MEDI0618Phase 21 trial
AbbVie · Migraine
- MEN1703SEL24, Dapolsertib hydrochloridePhase 21 trial
Ryvu Therapeutics SA · Non-Hodgkin Lymphoma, B-cell
- MEN2312Phase 21 trial
Stemline Therapeutics, Inc. · Hematological Malignancy
- MerestinibLY2801653Phase 21 trial
Eli Lilly · Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer
- MET233Phase 21 trial
Pfizer · Obesity and Obesity-related Medical Conditions
- MF-300Phase 21 trial
Epirium Bio Inc. · Sarcopenia in Elderly
- MGT-006Phase 21 trial
Metagen Therapeutics, Inc. · Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
- MHB009CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor
- MHB034CPhase 21 trial
Minghui Pharmaceutical (Shanghai) LTD · Advanced Malignant Solid Tumor
- MHB042CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Malignant Solid Tumor
- MHB046CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · Advanced Solid Cancer
- MHB048CPhase 21 trial
Minghui Pharmaceutical (Hangzhou) Ltd · mCRPC (Metastatic Castration-resistant Prostate Cancer), Advanced Malignant Solid Tumor
- MHS-1031Panosyl-isomaltooligosaccharidePhase 21 trial
Microbiome Health Sciences · Gastroesophageal Reflux
- MIL116Phase 21 trial
Beijing Mabworks Biotech Co., Ltd. · Immunoglobulin A Nephropathy
- MIT-001Phase 21 trial
MitoImmune Therapeutics · Head and Neck Squamous Cell Carcinoma, Oral Mucositis
- MIV-818Phase 21 trial
Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases
- MizagliflozinPhase 21 trial
Vogenx, Inc. · Postbariatric Hypoglycemia
- MK-1200Phase 21 trial
Merck & Co. · Advanced Solid Tumors
- MK-1439APhase 21 trial
Merck & Co. · Human Immunodeficiency Virus (HIV) Infection
- MK-2214Phase 21 trial
Merck & Co. · Early Alzheimer's Disease
- MK-2750Phase 21 trial
Merck & Co. · Advanced Solid Tumors, Malignant Neoplasm
- MK-6916Phase 21 trial
Merck & Co. · Pain Management
- MK-8690PRA052Phase 21 trial
Merck & Co. · Colitis Ulcerative, Ulcerative Colitis
- MKP10241Phase 21 trial
Mankind Pharma Limited · Type 2 Diabetes Mellitus (T2DM), Food Effect, Safety and Tolerability
- ML-016iNPG-pDoxPhase 21 trial
BrYet US, Inc. · Advanced Solid Tumor With Lung and/or Liver Involvement
- MLD10Phase 21 trial
Pharmalyte Solutions LLC · Hypomagnesemia in Type 2 Diabetic Patients
- MN-001Phase 21 trial
MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.